BiotechBrandon

MITC Readying for a Recovery?

Largo
NASDAQ:MITC   None
Its been a brutal year for Nasdaq, and $MITC is no exception. Its been tracking downwards since December after the Black Friday dip in major US indexes. While $MITC has underperformed $NDX, its smaller enterprise value makes this equity more vulnerable to background volatility, and the fact that the MITC and NDX price action's have followed the same course indicates a tight nexus. That said, we may be in for a reversal soon, and the fact that $MITC's RSI is in undervalued territory speaks to this. MACD is also moving in a positive direction, so I for one am banking on the fact that once NASDAQ reestablishes its foot, $MITC will be right up there with it.

Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.